What are the indications, dosing regimens, contraindications, and common side effects of amoxicillin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amoxicillin: Clinical Overview

Amoxicillin is a broad-spectrum, acid-stable penicillin antibiotic that serves as first-line therapy for numerous bacterial infections due to its excellent oral bioavailability, safety profile, and activity against common respiratory and soft tissue pathogens.

Indications

Primary Indications (Adults and Pediatric Patients)

Amoxicillin is indicated for infections caused by susceptible organisms in the following conditions 1:

  • Upper respiratory tract infections (ear, nose, throat)
  • Lower respiratory tract infections (community-acquired pneumonia, bronchitis)
  • Genitourinary tract infections (uncomplicated UTIs)
  • Skin and soft tissue infections

Specific Clinical Applications

Community-Acquired Pneumonia (CAP):

  • Preferred oral agent for mild-to-moderate CAP in children and adults 2
  • Pediatric dosing: 50-75 mg/kg/day in 2 doses 2
  • Adult dosing: 500 mg three times daily 3

Acute Otitis Media and Sinusitis:

  • Standard dose: 45 mg/kg/day for mild disease without recent antibiotic exposure 4
  • High-dose regimen (90 mg/kg/day) is preferred for moderate disease, recent antibiotic use (within 4-6 weeks), or areas with high penicillin-resistant S. pneumoniae prevalence 4

Skin and Soft Tissue Infections:

  • Impetigo: 25 mg/kg/day of amoxicillin component (when combined with clavulanate) in 2 divided doses 5
  • Effective against Staphylococcus and Streptococcus species when β-lactamase production is not a concern 5

Lyme Disease:

  • Adults: 500 mg three times daily 3
  • Children: 50 mg/kg/day in 3 divided doses (maximum 500 mg per dose) 3
  • Duration: typically 14-21 days for early localized disease

Severe Acute Malnutrition (Uncomplicated):

  • Oral amoxicillin is the preferred agent 6
  • Dosing varies from 50-100 mg/kg/day depending on guideline source

Febrile Infants (29-60 days):

  • For urinary tract infections: Ceftriaxone 50 mg/kg/dose every 24 hours is preferred, but oral cephalexin or cefixime may be used in infants >28 days 7

Adult-Only Indication

Helicobacter pylori infection and duodenal ulcer disease 1:

  • Triple therapy: 1 gram amoxicillin + 500 mg clarithromycin + 30 mg lansoprazole, all twice daily for 14 days
  • Dual therapy: 1 gram amoxicillin + 30 mg lansoprazole, three times daily for 14 days

Dosing Regimens

Standard Dosing

Adults:

  • Range: 750-1750 mg/day in divided doses every 8-12 hours 1
  • Typical dose: 500 mg three times daily or 875 mg twice daily
  • Maximum: 4 grams/day for high-dose regimens 4

Pediatric Patients (>3 months):

  • Range: 20-45 mg/kg/day in divided doses every 8-12 hours 1
  • Standard dose: 40-45 mg/kg/day
  • High-dose: 90 mg/kg/day (for resistant organisms or moderate-to-severe infections) 4

Neonates and Infants (≤3 months):

  • Maximum: 30 mg/kg/day divided every 12 hours 1

Duration of Therapy

Short-course therapy is increasingly supported by evidence:

  • CAP in children: 5 days of amoxicillin is non-inferior to 10 days 8
  • Uncomplicated infections: 3-5 day courses may be adequate for select conditions 8

Renal Dosing Adjustments

Reduce dose in severe renal impairment (GFR <30 mL/min) 1. Specific adjustments should be based on creatinine clearance and severity of infection.

Amoxicillin vs. Amoxicillin-Clavulanate

Use amoxicillin alone whenever possible to minimize adverse effects and preserve the effectiveness of β-lactamase inhibitors 9.

Amoxicillin-clavulanate is indicated when:

  • β-lactamase-producing organisms are suspected (H. influenzae, M. catarrhalis, S. aureus)
  • Recent antibiotic failure with amoxicillin alone
  • Moderate-to-severe infections requiring broader coverage 4

High-dose amoxicillin-clavulanate formulations:

  • Adults: 4 g amoxicillin + 250 mg clavulanate daily 4
  • Children: 90 mg/kg/day amoxicillin + 6.4 mg/kg/day clavulanate in 2 divided doses 4
  • The 14:1 ratio (pediatric) minimizes clavulanate-related diarrhea 4

Contraindications

Absolute contraindications 1:

  • History of serious hypersensitivity reactions (anaphylaxis, Stevens-Johnson syndrome) to amoxicillin or other β-lactams (penicillins, cephalosporins)

Relative contraindications:

  • Infectious mononucleosis (high risk of erythematous rash) 1
  • Severe renal impairment without dose adjustment

Common Side Effects

Most Common (>1%) 1

  • Diarrhea (particularly with amoxicillin-clavulanate: 7-8% in clinical trials)
  • Rash (non-allergic maculopapular rash common)
  • Vomiting
  • Nausea

Serious Adverse Events 1

Hypersensitivity reactions:

  • Anaphylaxis (rare but potentially fatal)
  • Serum sickness-like reactions
  • Hypersensitivity vasculitis

Severe cutaneous adverse reactions (SCAR):

  • Stevens-Johnson syndrome (SJS)
  • Toxic epidermal necrolysis (TEN)
  • Drug reaction with eosinophilia and systemic symptoms (DRESS)
  • Acute generalized exanthematous pustulosis (AGEP)
  • Monitor closely and discontinue if rash progresses 1

Clostridioides difficile-associated diarrhea (CDAD):

  • Can range from mild diarrhea to fatal colitis
  • May occur up to 2 months after antibiotic discontinuation 1
  • Higher risk with amoxicillin-clavulanate than amoxicillin alone 10

Other notable adverse effects:

  • Mucocutaneous candidiasis (Number Needed to Harm: 27 for amoxicillin with or without clavulanate) 10
  • Hepatic dysfunction (cholestatic jaundice, hepatitis)
  • Crystalluria (rare)
  • Tooth discoloration (primarily in children; reversible with dental cleaning) 1
  • Hematologic abnormalities (hemolytic anemia, thrombocytopenia—usually reversible)

Quantified Harm Data

From systematic review of placebo-controlled trials 10:

  • Diarrhea with amoxicillin-clavulanate: Odds ratio 3.30 (95% CI 2.23-4.87); Number Needed to Harm = 10
  • Candidiasis: Odds ratio 7.77 (95% CI 2.23-27.11); Number Needed to Harm = 27
  • Rashes, nausea, vomiting, and abnormal liver function tests were not significantly increased compared to placebo

Important Drug Interactions 1

Probenecid:

  • Decreases renal tubular secretion of amoxicillin
  • Results in increased and prolonged blood levels
  • Coadministration not recommended 1

Oral anticoagulants:

  • May increase prothrombin time prolongation
  • Monitor INR closely 1

Allopurinol:

  • Increases risk of rash
  • Use with caution 1

Oral contraceptives:

  • May reduce efficacy
  • Advise backup contraception 1

Clinical Pearls and Pitfalls

Pharmacokinetic advantages:

  • Amoxicillin has twice the oral bioavailability of ampicillin, allowing for lower doses with equivalent efficacy 11
  • Absorption is not affected by food, unlike many other antibiotics 9
  • Serum levels increase linearly with dose—no absorption ceiling 4

Resistance considerations:

  • Amoxicillin is the most active oral β-lactam against S. pneumoniae, including penicillin-resistant strains when high-dose regimens are used 4
  • High-dose amoxicillin (90 mg/kg/day in children, 4 g/day in adults) overcomes relative penicillin resistance 4
  • First-generation cephalosporins (e.g., cephalexin) are inactive against B. burgdorferi and should not be used for Lyme disease 3

Common prescribing errors to avoid:

  • Using amoxicillin-clavulanate when amoxicillin alone would suffice (increases adverse effects without added benefit) 9
  • Underdosing in moderate-to-severe infections or areas with resistant organisms 4
  • Prescribing for viral infections or mononucleosis 1
  • Failing to adjust dose in renal impairment 1

Antimicrobial stewardship:

  • Prescribe amoxicillin only for proven or strongly suspected bacterial infections 1
  • Consider delayed prescribing strategies for self-limiting conditions 9
  • Use shortest effective duration (often 5 days for uncomplicated infections) 8

References

Guideline

antimicrobial treatment guidelines for acute bacterial rhinosinusitis.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2004

Research

Oral amoxicillin and amoxicillin-clavulanic acid: properties, indications and usage.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2020

Research

Common harms from amoxicillin: a systematic review and meta-analysis of randomized placebo-controlled trials for any indication.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2015

Related Questions

I completed a 10‑day course of amoxicillin two weeks ago and now have persistent throat redness, irritation, a cobblestone‑appearing oropharynx and a dry cough; what should I do?
What is the appropriate weight‑based dosing of amoxicillin for pediatric patients, including recommended mg/kg per day and dosing intervals for mild to moderate versus severe infections?
What is the appropriate management for a rash that develops during amoxicillin therapy?
What are the indications, dosing regimens, and precautions for amoxicillin in adults and children?
What is the appropriate dose (volume) of 400 mg/5 mL amoxicillin suspension for a 34‑lb (≈15 kg) child?
Should a patient whose blood pressure has fallen to 133/44 mmHg (hypotension) with a pulse of 54 bpm (bradycardia) after two 25 mg doses of hydralazine given 1.5 hours apart, followed by 5 mg amlodipine and 80 mg valsartan, receive another dose of hydralazine now?
What is the appropriate evaluation and management of renal calcinosis?
What is the normal intravenous push dose of hydromorphone (Dilaudid) for an opioid‑naïve adult with acute severe pain?
What is the appropriate management of acute kidney injury in a pregnant woman?
What is the normal dose of fentanyl for intravenous push in an opioid‑naïve adult?
Given that hydralazine was administered 7.5 hours ago and amlodipine (calcium‑channel blocker) and valsartan (angiotensin‑II receptor blocker) were given 6 hours ago, with the current blood pressure 133/44 mmHg and pulse 54 bpm, when should the next doses of valsartan and amlodipine be given?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.